Skip navigation

Chemical Nicergoline

Name Nicergoline
CAS Type 1 Name Ergoline-8-methanol, 10-methoxy-1,6-dimethyl-, 5-bromo-3-pyridinecarboxylate (ester), (8beta)-
Equivalent Terms Circo Maren | Circo-Maren | Ergobel | F.I. 6714 | Fisifax | Nicergobeta | Nicergolin Atid | Nicergolin Lindo | Nicergolin Neuraxpharm | Nicergolin-Neuraxpharm | Nicergolin Ratiopharm | Nicergolin-Ratiopharm | Nicergolin TEVA | Nicergolin-TEVA | Nicergolin Von Ct | Nicerium | Nicotergoline | Nimergoline | Sermion | Von Ct, Nicergolin
CAS Registry Number 27848-84-6
Definition An ergot derivative that has been used as a cerebral vasodilator and in peripheral vascular disease. It may ameliorate cognitive deficits in CEREBROVASCULAR DISORDERS.
Structure Nicergoline
Curation Status No gene interactions have been curated for this chemical yet.
MeSH® ID D009530
External Links

Top ↑ Ancestors

1. ChemicalsHeterocyclic Compounds Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references Alkaloids Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references Ergot Alkaloids Has associated genes Has associated diseases Has associated phenotype references Ergolines Has associated genes Has associated diseases Has associated phenotype references Nicergoline Has associated diseases Has associated phenotype references
2. ChemicalsHeterocyclic Compounds Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references Heterocyclic Compounds, Fused-Ring Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references Heterocyclic Compounds, 4 or More Rings Has associated genes Has associated diseases Has associated phenotype references Has associated exposure references Ergolines Has associated genes Has associated diseases Has associated phenotype references Nicergoline Has associated diseases Has associated phenotype references

Top ↑ Descendants

None.